Cargando…
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169058/ https://www.ncbi.nlm.nih.gov/pubmed/34087093 http://dx.doi.org/10.1016/S2352-3018(21)00099-0 |
| _version_ | 1783701982195744768 |
|---|---|
| author | Touizer, Emma Alrubayyi, Aljawharah Rees-Spear, Chloe Fisher-Pearson, Natasha Griffith, Sarah A Muir, Luke Pellegrino, Pierre Waters, Laura Burns, Fiona Kinloch, Sabine Rowland-Jones, Sarah Gupta, Ravindra K Gilson, Richard Peppa, Dimitra McCoy, Laura E |
| author_facet | Touizer, Emma Alrubayyi, Aljawharah Rees-Spear, Chloe Fisher-Pearson, Natasha Griffith, Sarah A Muir, Luke Pellegrino, Pierre Waters, Laura Burns, Fiona Kinloch, Sabine Rowland-Jones, Sarah Gupta, Ravindra K Gilson, Richard Peppa, Dimitra McCoy, Laura E |
| author_sort | Touizer, Emma |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8169058 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81690582021-06-02 Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV Touizer, Emma Alrubayyi, Aljawharah Rees-Spear, Chloe Fisher-Pearson, Natasha Griffith, Sarah A Muir, Luke Pellegrino, Pierre Waters, Laura Burns, Fiona Kinloch, Sabine Rowland-Jones, Sarah Gupta, Ravindra K Gilson, Richard Peppa, Dimitra McCoy, Laura E Lancet HIV Correspondence Elsevier Ltd. 2021-06 2021-06-01 /pmc/articles/PMC8169058/ /pubmed/34087093 http://dx.doi.org/10.1016/S2352-3018(21)00099-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Touizer, Emma Alrubayyi, Aljawharah Rees-Spear, Chloe Fisher-Pearson, Natasha Griffith, Sarah A Muir, Luke Pellegrino, Pierre Waters, Laura Burns, Fiona Kinloch, Sabine Rowland-Jones, Sarah Gupta, Ravindra K Gilson, Richard Peppa, Dimitra McCoy, Laura E Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV |
| title | Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV |
| title_full | Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV |
| title_fullStr | Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV |
| title_full_unstemmed | Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV |
| title_short | Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV |
| title_sort | failure to seroconvert after two doses of bnt162b2 sars-cov-2 vaccine in a patient with uncontrolled hiv |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169058/ https://www.ncbi.nlm.nih.gov/pubmed/34087093 http://dx.doi.org/10.1016/S2352-3018(21)00099-0 |
| work_keys_str_mv | AT touizeremma failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT alrubayyialjawharah failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT reesspearchloe failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT fisherpearsonnatasha failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT griffithsaraha failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT muirluke failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT pellegrinopierre failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT waterslaura failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT burnsfiona failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT kinlochsabine failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT rowlandjonessarah failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT guptaravindrak failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT gilsonrichard failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT peppadimitra failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv AT mccoylaurae failuretoseroconvertaftertwodosesofbnt162b2sarscov2vaccineinapatientwithuncontrolledhiv |